Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y P Hu

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1996
On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistanceY P Hu, S Jarillon, C Dubernet, et al.
Anti-Cancer Drugs|September 1, 1996
Effects of modulators of multidrug resistance on the expression of the MDR1 gene on human KB cells in cultureY P Hu, P Pourquier, F Doignon, et al.
Biochemistry|May 2, 2001
Hypersensitization of tumor cells to glycolytic inhibitorsH Liu, Y P Hu, N Savaraj, et al.
International Journal of Oral and Maxillofacial Surgery|September 27, 2006
Clinical review of three types of platysma myocutaneous flapT Su, Y-F Zhao, B Liu, et al.
International Journal of Pharmaceutics|April 25, 2003
Biodegradable polymeric microspheres for nalbuphine prodrug controlled delivery: in vitro characterization and in vivo pharmacokinetic studiesFang-I Liu, J H Kuo, K C Sung, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1993
[Reversal of adriamycin resistance by verapamil and ligustrazini in mouse Ehrlich ascites cancer]Y P Hu, J Lin, Q D Wang, et al.
World Journal of Gastroenterology|January 31, 2002
Inhibition of hepatitis B virus by oxymatrine in vivoX S Chen, G J Wang, X Cai, et al.
Yi Chuan Xue Bao = Acta Genetica Sinica|January 19, 2002
[The presentation of neo gene in chimeric mice obtained from ES cells]Y C Yao, J Xiong, X M Wang, et al.
Journal of Occupational and Environmental Medicine|May 29, 2000
Measurement of percutaneous uptake of 2-methoxy ethanol vapor in humansT S Shih, P Y Wang, C Y Chen, et al.
Anti-Cancer Drugs|July 1, 1997
Cellular pharmacology of lipophilic anthracyclines in human tumor cells in culture selected for resistance to doxorubicinS Bennis, P Faure, C Chapey, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|January 1, 1996
On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistanceY P Hu, S Jarillon, C Dubernet, et al.
Anti-Cancer Drugs|September 1, 1996
Effects of modulators of multidrug resistance on the expression of the MDR1 gene on human KB cells in cultureY P Hu, P Pourquier, F Doignon, et al.
Biochemistry|May 2, 2001
Hypersensitization of tumor cells to glycolytic inhibitorsH Liu, Y P Hu, N Savaraj, et al.
International Journal of Oral and Maxillofacial Surgery|September 27, 2006
Clinical review of three types of platysma myocutaneous flapT Su, Y-F Zhao, B Liu, et al.
International Journal of Pharmaceutics|April 25, 2003
Biodegradable polymeric microspheres for nalbuphine prodrug controlled delivery: in vitro characterization and in vivo pharmacokinetic studiesFang-I Liu, J H Kuo, K C Sung, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1993
[Reversal of adriamycin resistance by verapamil and ligustrazini in mouse Ehrlich ascites cancer]Y P Hu, J Lin, Q D Wang, et al.
World Journal of Gastroenterology|January 31, 2002
Inhibition of hepatitis B virus by oxymatrine in vivoX S Chen, G J Wang, X Cai, et al.
Yi Chuan Xue Bao = Acta Genetica Sinica|January 19, 2002
[The presentation of neo gene in chimeric mice obtained from ES cells]Y C Yao, J Xiong, X M Wang, et al.
Journal of Occupational and Environmental Medicine|May 29, 2000
Measurement of percutaneous uptake of 2-methoxy ethanol vapor in humansT S Shih, P Y Wang, C Y Chen, et al.
Anti-Cancer Drugs|July 1, 1997
Cellular pharmacology of lipophilic anthracyclines in human tumor cells in culture selected for resistance to doxorubicinS Bennis, P Faure, C Chapey, et al.
Pageof 6